Trial intelligence / Profile preview

Effect of magnesium sulfate on induced opiate withdrawal syndrome

IRCT20190207042648N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in opioid withdrawal, sponsored by Mashhad University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

opioid withdrawal

Beyond the preview

Go deeper on IRCT20190207042648N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190207042648N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call